Kramer MS, Kahn SR, Platt RW, Genest J, Rozen R, Chen MF, et al
SELECT Trial Semaglutide and Cardiovascular Outcomes (NEJM, 2023): 20% reduction in major adverse cardiovascular events with Wegovy in overweight/obesity
Slight decrease in energy levels or passing headaches as your body adjusts to lower caloric intakes
Clin Cosmet Investig Dermatol 10, 147153.CrossRefGoogle ScholarPubMed Tong, J, Fitzmaurice, PS, Moszczynska, A, et al
The concern: the same pathways that promote healing can also be hijacked by cancer cells
It can be a good starting point for visual learners: GLP-1 stands for Glucagon-Like Peptide-1